Pharmaceutical Webinar Recordings
Missed a Pharma Intelligence webinar? View our comprehensive list of webinars below.
Meddevicetracker, Medtech Insight
Neuromodulation Device Market - Innovations and Trends
29 October 2018
The large and growing global market for implantable neurostimulation devices is approaching nearly $4 billion worldwide and is one of the highest growth medical device markets today and undergoing significant technological advancement by innovative start-ups and leading medical device companies. Experts from Meddevicetracker and Medtech Insights explored this exciting area in this webinar, which focused on three targeted neuromodulation segments, spinal cord stimulation (SCS), deep brain stimulation (DBS) and vagus nerve stimulation (VNS), looking at the market size, growth, and key players as well as opportunities and key challenges.
2017 Completed Clinical Trials: Status Quo or No?
24 July 2018
A completed clinical trial landscape provides a more granular view of how companies are progressing their pipelines and the disease strategies they are pursuing, compared to static pipeline snapshots. Discover the state of last year's completed trials and successes, with a deep dive into the active landscapes of oncology, autoimmune/inflammation, and CNS trials and insights into sponsor drug and disease strategies.
Japan Pharma Outlook: Strategizing Growth in an Evolving Industry Landscape
20 June 2018
Japan Pharma must navigate complex pressures and opportunities presented by an aging and declining Japanese population, as well as government measures designed to encourage innovation while controlling healthcare spending, to steer a path towards long-term global revenue growth. Gain an inside view from experts on the significant growth potential of the industry, as they examine ten prominent Japanese companies and their strategies to maximize global revenue in the Japan Pharma Outlook webinar.
Pharma Intelligence with the Alliance for Regenerative Medicine
RMAT Designation: Impact on Regenerative Medicine Sector & How it Compares with Other Accelerated Approval Programs
13 June 2018
The 21st Century Cures Act, passed in December 2016, included several key regenerative medicine-specific provisions, one of which led to the creation of the Regenerative Medicine Advanced Therapies (RMAT) designation, creating an optimized, accelerated approval program specifically designed with the unique attributes of regenerative medicine products in mind. This webinar, hosted by Pharma Intelligence in partnership with the Alliance for Regenerative Medicine, explores the significance of this designation and the ongoing interest and support of the FDA to advance this critically important sector.
Medtech Insights, Meddevicetracker
Robotic Surgery 4.0 Innovative Robotic Assisted Systems & their Applications
6 June 2018
Robotic surgery is revolutionizing the patient experience and as technology advances, competition in the robotic surgery devices space is growing exponentially. Take a closer look at the expanding robotic surgery market during this webinar from Medtech Insight and Meddevicetracker: Robotic Surgery 4.0: Innovative Robotic Assisted Systems & Their Applications.
ASCO Essentials Webinar 2018 Recording
23 May 2018
Just in time for your 2018 ASCO Annual Meeting planning, join analysts from Datamonitor Healthcare, Biomedtracker, Citeline, Scrip, and Pink Sheet for their expert opinions on what you need to know to get the most from the meeting
Let our experts present their top picks from the thousands of abstracts being presented at ASCO
Pharma R&D review Webinar
16 May 2018
Keep in tune with the current landscape for pharma R&D with this free, information-packed webinar recording from Informa Pharma Intelligence. In the Global Pharma R&D Review webinar, our experts hit all the right notes as they use a music theme to explore key issues affecting R&D today, and offer a glimpse of what the rest of 2018 may look like.
Companion Diagnostics Webinar
15 May 2018
Companion diagnostics are poised to be a huge growth area worldwide, with a CAGR of 20.1% over the next 5 years, making it a $6B industry by 2022. Learn more about this important, emerging area with the Companion Diagnostics Webinar recording from Informa Pharma Intelligence.
Partnership shared expertise and technology to optimize study planning webinar
24 April 2018
The 9th Annual SCOPE (Summit for Clinical Trials Operations Executives) Summit has concluded: join industry expert and clinical trial planning thought leader Loni Branon as she hosts a follow-up to this important annual event, where Informa Pharma Intelligence hosted a launch party for our exciting new Citeline platform. In collaboration with guest speakers from Bayer and ICON, our presenters share insights on how combining expertise with trusted partners, along with a few simple tech tools, can streamline the study start up journey.
HIV Market Growth webinar
19 April 2018
Mr. Haydock & Mr. Haas used the exclusive information within Datamonitor Healthcare and Biomedtracker to present a view of the market for HIV drugs. Informa Pharma Intelligence forecasts HIV sales revenues to increase in the US and five major EU markets to a peak of $22.7bn in 2024 before generic erosion triggers a market decline.
Dyslipidemia Market Overview
31 January 2018
Important changes are coming to the Dyslipidemia market in the coming months and years, with Datamonitor Healthcare forecasting sales from the US dyslipidemia market to rise to $22.3bn in 2025. Stay in the loop by registering for the upcoming webinar from Biomedtracker and Datamonitor Healthcare.
Biosimilars Development in Autoimmune and Inflammatory Diseases
11 October 2017
The Informa Pharma Intelligence webinar recording, "Biosimilars Development in Autoimmune and Inflammatory Diseases", is now available to watch. We hope you find the recording of the webinar helpful in gaining insight into the factors driving the biosimilars market for blockbuster drug trials helpful.
Choice Not Chance: How to Mitigate the Risk of Selecting a Non-Enrolling Site for your Clinical Trial
19 September 2017
Patient recruitment into clinical trials is a challenging endeavor with 1 in 10 sites, on average, failing to enroll a single patient into a trial. Learn about strategies to help reduce the chance of selecting a non-enrolling site by viewing the webinar recording below.
2016 Clinical Trials Roundup
20 September 2017
The Clinical Trials Roundup provides an annual view of the trial landscape of the year just past, dissecting the data by therapeutic area, phase, disease, company, and more. Watch the recording of "2016 Clinical Trials Roundup: The Next Generation" to gain insight into competitive drug development strategies, presented to you by Citeline's Trialtrove, part of the Informa Pharma Intelligence family of tools.
Heart Valve Disorder and Management Markets
21 September 2017
We’d like to now invite you to download a free recording of this webinar, which offers critical insights and updates into the rapidly growing heart valve devices market.
Medtech Insight, In Vivo
The Trump Era: Challenges and Opportunities in Pharma and Medtech Policy
27 July 2017
The Trump Era: Challenges and Opportunities in Pharma and Medtech Policy, presented by senior expert analysts from Informa Pharma Intelligence. We hope you found the session to be an insightful and informative view into the implications of the first 100 days of Trump’s presidency upon the pharma and medtech industries.
View webinar recording
Oncology Success Rates
21 July 2017
Learn more about benchmarking, and the successes, or lack of success, in oncology drug development in the webinar "Oncology Success Rates", presented by: Robert Jeng, Senior Scientific Analyst, Will Akie, Product Manager for Pharmapremia, and Ellen Moore of Pharma Consulting.
2016 Completed Clinical Trials: Industry Strategies Revealed and Graded
17 July 2017
Delving into clinical trial completions provides additional insight that support comparisons of companies' strategies and performances. Using exclusive data from Citeline's Trialtrove, part of the Informa Pharma Intelligence suite of tools, our analysts will go beyond the numbers and dig into the granular details and their implications.
Big Pharma Outlook 2026
03 July 2017
Big Pharma is poised for growth due to strong launch portfolios, the availability of high-potential pipeline assets, and companies’ sharpened focus on high-performing markets. Watch the Big Pharma Outlook webinar recording below and discover how Big Pharma will navigate challenging times for the industry in order to steer towards robust growth.
From R&D Investment to Externalization: Where is the Pharma Industry Maximizing Value?
13 June 2017
In the developing pharma landscape, it's important to consider all variables to create a winning portfolio strategy. Pharmaceutical companies are attempting to maximize value from all angles, including internal investment in R&D and externalization via deal-making. Learn more about these two models in the webinar recording below.
Datamonitor Healthcare, RxScorecard
Market Access & Reimbursement: Inside the Payer Perspective on Multiple Myeloma
08 June 2017
The multiple myeloma market is evolving, with new therapies and questions about the future of care. Learn about the current assessment payers use for therapies, as well as the significant changes we were seeing in this market during "Market Access & Reimbursement: Inside the Payer Perspective on Multiple Myeloma."
R&D Annual Review Webinar
17 May 2017
In this annual look at the evolution of pharma R&D, we will discuss the industry trends by examining the pipeline by company, therapeutic area, disease, target, and drug type, using data from Pharmaprojects.
Winter is coming: Clinical Trial and Site Selection Optimization for Seasonal Respiratory Vaccines
06 December 2016
Get a view of the clinical trial landscape while discovering strategies to optimize site selection within the unique area of developing seasonal respiratory vaccines, including Respiratory Syncytial Virus (RSV) and influenza.
Medtech Insight, Meddevicetracker, In Vivo
21 September 2016
Listen to Amanda Maxwell, Regulatory Affairs Editor, David Filmore, Executive Editor, and Ashley Yeo, Principle Analyst as they focus on medtech regulation and the key changes that are likely to impact the industry in the coming months/years.